A new medical solution could change the way producers treat cattle for pain.
Merck Animal Health unveils Banamine® Transdermal, a topical Banamine® solution. The Iowa Agribusiness Radio Network spoke to Dr. Kevin Hill, technical services veterinarian for Merck Animal Health, at the National Cattlemen’s Beef Association (NCBA) Convention in Phoenix, AZ. Dr. Hill says Banamine® Transdermal, a non-steroidal anti-inflammatory, is a breakthrough for therapeutics in cattle.
“Banamine® Transdermal is the first FDA licensed product to control pain and fever through a topical administration,” Dr. Hill said. “This just gives them a simple and effective way to administer banamine without having to use a syringe and needle.”
Producers can treat cattle with Banamine® Transdermal to reduce fever associated with respiratory disease or pain associated with foot rot. Dr. Hill says producers can also use Banamine® Transdermal as an adjunct therapy.
“The most common health problem we have in cattle is respiratory disease. A very common approach is to get those animals started on an antibiotic and then bring the fever down with banamine transdermal, and that helps the recovery process,” Dr. Hill said.
Dr. Hill says not only will Banamine® Transdermal change the way producers treat cattle, it will change things on the consumer front.
“Violative residues of any kind of drug is an important aspect for agriculture that producers take very seriously. Unfortunately, one of the top violative residues over the past few years has been flunixin because it has been used for pain relief that’s been associated with intramuscular or subcutaneous use where the withdrawal times are very unclear.”
“Now, for the first time, we have a pour on product, easy-to-give and an established withdrawal period of eight days. There’s no question of when that animal’s ready to go and we then have the opportunity to pull that problem off food consumer’s problem list,” Dr. Hill said.”
For more information about Banamine® Transdermal, visit www.banaminetd.com.